Expression of the human concentrative nucleotide transporter 1 (hCNT1) gene correlates with clinical response in patients affected by Waldenström's Macroglobulinemia (WM) and small lymphocytic lymphoma (SLL) undergoing a combination treatment with 2-chloro-2′-deoxyadenosine (2-CdA) and Rituximab

Autor: Rabascio, C., Laszlo, D., Andreola, G., Saronni, L., Radice, D., Rigacci, L., Fabbri, A., Frigeri, F., Calabrese, L., Billio, A., Bertolini, F., Martinelli, G.
Zdroj: In Leukemia Research 2010 34(4):454-457
Databáze: ScienceDirect
Externí odkaz: